Description
The Department of Veterans Affairs intends to award a sole source contract for the provision of Amyvid (Florbetapir F 18), a diagnostic PET radiopharmaceutical used in adults with thinking or memory problems who are being assessed for Alzheimer’s Disease (AD) or other causes of these symptoms. The contractor shall provide delivery of 10.0 mCi doses of intravenous Amyvid (Florbetapir F 18) to the Nuclear Medicine Hot Lab at the New Jersey Health Care System (VANJHCS) at East Orange on an as-needed basis. The contractor must be licensed by the Nuclear Regulatory Commission and meet various federal and state regulations.
Key requirements include:
• Providing Amyvid (Florbetapir F 18) with adequate labeling, including amounts, preparation time, expiration time, and date
• Providing a bar code labeled insert for scanning data into the VAMC’s nuclear medicine information management system (NMIS)
• Meeting Department of Transportation, NHPP, FDA, OSHA, and other agency rules and regulations
• Providing copies of licenses and certifications along with proposals